Scientist / Manager Scientist

CURRICULUM VITAE

May, ****

IAN KEITH McNIECE

Personal

Home: *** ******* ******, ***** ******, FL 33134, U.S.A. Ph. 305-***-****.

Email: **********@***.***

Business: University of Miami, CRB room 1113, 1120 NW 14th Street, Miami, FL, 33136, U.S.A. Ph.305-***-****, Email: ********@***.*****.***.

DATE OF BIRTH: March 22, l954 PLACE OF BIRTH: Australia

NATIONALITY: Australia and USA

MARITAL STATUS: Married, Peggy McNiece

Education

B.Sc. Melbourne University, Melb. Australia l979, Bio¬chemistry

M.Sc. (prelim) Melbourne University, l98l, Physiology

Ph.D. Melbourne University, l986, Physiology. Thesis Title: Studies of purification and biological action of synergistic factor from WEHI 3B conditioned medium. Supervisors: AB Kriegler, Ph.D. (Cancer Institute), TR Bradley, Ph.D. (Cancer Institute), NT Williams, Ph.D. (Melbourne University).

Appointments

Pre-Doctoral:

1973 1975 Royal Children's Hospital, Melbourne, Australia Technical Assistant

1975 1976 Cancer Institute, Melbourne, Australia Technical Assistant

1977 1978 Melbourne University, Melbourne, Australia Technical Assistant

1978 1985 Cancer Institute, Melbourne, Australia Senior Research Technologist

PostDoctoral:

1986 Cancer Institute, Melbourne, Australia Postdoctoral Fellow

1986 1988 University of Virginia, Charlottesville, Virginia, USA Postdoctoral Fellow.

1988-1994 Amgen Inc., Thousand Oaks, California, USA - Research Scientist

1994-1997 Amgen Inc, TO, CA, USA - Laboratory Head, Dept of Developmental Hematology

1995-1997 Head, Amgen Central Laboratory, St Luc University Hospital, Brussels, Belgium.

1997-1998 Joint appointment: University of California at Santa Barbara, California, USA - Adjunct Professor, Dept. Of Molecular, Cellular and Developmental Biology.

1997-2002 University of Colorado Health Sciences Center, Denver CO, USA – Professor of Medicine

and Director of Research, Bone Marrow Transplant Program.

1997-2002 Joint appointment: University of Colorado HSC, Department of Pharmacology.

1999-2002 Joint appointment: University of Colorado HSC, Department of Immunology

2002 Director of Stem Cell Biology Program, University of Colorado HSC

2003- 2007 Professor of Oncology, Johns Hopkins University, Baltimore, MD

2003- 2007 Director of Cell Therapy Laboratory, JHMI, Baltimore, MD

2004- 2006 Director of the Division of Biomedical Science, Johns Hopkins in Singapore, Singapore

2004- 2006 CEO, Johns Hopkins Singapore, Singapore.

2007- present Professor of Medicine, Division of Cardiology, University of Miami, Miami, FL

2007- present Director, Experimental and Clinical Cell-Based Therapies Program, Stem Cell Institute,

University of Miami, Miami, FL.

Societies

American Society for Blood and Marrow Transplantation, 1995 - present

American Society of Hematology, 1990 - present

Australian & New Zealand Cell Biology Society, l982 1988

European Hematology Assoc, 1995-present

International Society for Experimental Hematology, l985 present

International Society for Cellular Therapy (formerly ISHAGE), 1995 - present

International Society for Stem Cell Research, 2003 - present

Society of Leukocyte Biology, 1992-1997

Editorial Appointments

Editorial Board, International Journal of Cell Cloning (1992-1993).

Editorial Board, Stem Cells (1993-present)

Associate Editor, Experimental Hematology (1998-2003)

International Editorial Board, Journal of Clinical and Experimental Hematopathology (2000 – present)

Editorial Board, Experimental Hematology (2004-2006)

Thesis Supervisor

David Lee, M.Sc. - Northridge Univ. 1995.

Steve Rosinski, PhD University of Colorado, 1998- 2003.

Julie Candia, MSc, Denver University, 1998-2001.

Other

ISHAGE Ex Vivo Expansion Committee, 1997 – 2004.

Scientific Advisory Board - 28th Annual Meeting of ISEH, 1999.

Laboratory Inspector - FACT Transplant Program Accreditation 1998- present.

Program Advisory Board - 10th Int Symposium on ABMT, 2000.

Membership Committee of ISEH, 2000 to 2002.

Ad hoc reviewer, Hematology I Study Section, NIH

Ad hoc reviewer, Regenerative Medicine Study Section, NIH

Ad hoc reviewer, NIAID, NIH

Ad hoc reviewer, NCI, NIH

Councillor of ISEH, 2002 - 2005

ISCT Hematopoietic Stem Cell Committee – Chair, 2004 – present.

Member – Advisory Board of the Faculty of Medicine, Dept of Medicine, Johns Hopkins Univ, 2004 to 2006

Committee Member - FACT Standards Committee, Cell Processing Lab Subcommittee, 2004 – present.

ISCT Annual meeting, Organizing committee 2005

Principal Investigator – FDA IND#12379 Ex vivo expanded Mafosfamide purged CD34+ cells, approved August, 2005.

Principal Investigator – FDA IND#12658 Ex vivo expanded CD133+ cord blood cells, approved October 2005.

Director – Board of Directors ES International, Singapore, 2006 - 2007.

ISCT Annual meeting, Organizing committee 2006.

Faculty member, Pathobiology Graduate Program, Johns Hopkins University, Baltimore, MD 2006-2007.

Member Scientific Advisory Board, National Stem Cell Inc, 2006 – present

ISCT Annual meeting, Organizing committee 2007.

ISCT 2008 Annual meeting, Maimi, FL – Co-Chair

Chief Scientific Officer – Proteonomix Inc, 2009 - present.

ISCT Annual meeting, Organizing committee 2009.

Chairperson – Univ of Miami ESCRO Committee 2009 – present.

Director – Board of Directors Foundation for the Accreditation of Cellular Therapy (FACT), 2010 - present

Contact this candidate